Departments of 1 Reproductive Biology, 2 Physiology and Biophysics and 3 Environmental Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In human cervical cells, extracellular ATP induces an acute decrease in the resistance of the lateral intercellular space, the phase I response, followed by a delayed increase in tight junctional resistance, the phase II response. These responses depend on vitamin A because incubation of cells in retinoid-free medium (RFM) abolished both responses. Treatment with retinoic acid restored the phase I response in full, but the amplitude of the phase II response was restored only partly. Shorter incubations and lower concentrations of retinoic acid [half-maximal effective concentration (K1/2) = 0.1 µM] were required for restoring the phase I response than were required for reversing the phase II response (K1/2 = 1 µM). The phase I response could be restored by ligands that bind to either retinoic acid receptors (RARs) or retinoid X receptors, but only RAR agonists had an effect on phase II response. RFM had no effect on decreases in resistance induced by ionomycin, but it attenuated phase II-like increases in resistance induced by KCl or by 1,2-dioctanoyl-sn-diglycerol (diC8). Actinomycin D blocked phase II response but not phase I response or the responses to ionomycin, KCl, or diC8. These results suggest that retinoids act on cervical cells via distinct retinoid receptor mechanisms and modulate phase I and phase II changes in resistance by regulating distinct signal mechanisms.
human; cervical cells; extracellular ATP; tight junctions; vitamin A; lateral intercellular space; transepithelial transport; cervical mucus
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
THE MAIN FUNCTION OF THE epithelium that covers the woman's endocervix is to control reproduction. This function depends on well-regulated secretion of fluid and solutes (the cervical mucus) from the epithelial cells that line the cervical lumen. Recently, we described an in vitro model of human cervical epithelial cells on filters that retain phenotypic characteristics of the endocervical epithelium, thus providing an appropriate in vitro model for the study of transcervical transport (20). The cultured cervical epithelium is also characterized by a relatively high degree of permeability compared with other, more occlusive epithelia (13, 19, 24).
More recent studies suggest that the permeability of the cultured cervical epithelium can be regulated. For instance, extracellular purines (ATP) or pyrimidines (UTP) at micromolar concentrations modulate the paracellular resistance acutely and reversibly (17). ATP stimulates two distinct effects that differ in their time course, signaling, and direction: an acute decrease in resistance (termed phase I response), which is mediated by calcium mobilization (18), acute decrease in cell volume, and subsequently a decrease in the resistance of the lateral intercellular space (RLIS) (13, 17). ATP also stimulates a delayed increase in paracellular resistance (termed phase II response), which is sensitive to pertussis toxin and is mediated by augmented calcium influx, activation of protein kinase C, and an increase in tight junctional resistance (RTJ) (17-19). The net effect on transcervical permeability is the composite of the two effects, and the measured changes in permeability are characterized by a transient decrease followed by a sustained increase in resistance (Ref. 18; see Fig. 1A).
Both effects of ATP were shown to be the result of activation of P2U receptors (17). On the basis of pharmacological criteria, it was suggested that phase I and phase II responses are mediated by two distinct P2U receptors. However, the possibility that the signals diverge downstream from a single receptor has not been ruled out. These novel data are relevant to the regulation of cervical mucus in vivo because epithelial cells express P2U purinergic receptors (7, 15, 17, 22, 23), and ATP can accumulate in the extracellular space at micromolar concentrations (4, 26), which are sufficient to activate the P2U receptor mechanisms.
Vitamin A and related compounds, the retinoids, regulate the reproductive tract epithelia in females (9, 10, 14-16, 21). Vitamin A deficiency results in dryness of mucus membranes (9) and may lead to squamous metaplasia and keratinization of the simple columnar epithelium of the endocervix (10). Recent in vitro studies showed that retinoids regulate the paracellular permeability across the cultured human cervical epithelium (14). The objective of the present study was to study the effect of retinoids on the changes in paracellular resistance induced by the P2U receptor pathways. Our results show that the phase I and phase II responses are differentially regulated by retinoic acid receptor (RAR)- vs. retinoid X receptor (RXR)-selective retinoids.
![]() |
METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cell Culture Techniques
Experiments were done on CaSki cells, which retain phenotypic characteristics of human endocervical cells (20). CaSki cells form a confluent and polarized epithelium on filters, and the cells express tight junctions that occlude effectively the intercellular space (13, 17-20). The growth of CaSki cells on filters depends on the mode of plating: when plated at low density, cells will reach confluency within 1-2 wk and will form a monolayer; when plated at high density, e.g., as for present study, cells will remain attached on the filter as a bi- and/or trilayer (20). In the latter case, the basal layer contains a confluent layer of vital cells that determines the permeability properties of the epithelium (19, 20). The cells in the superficial layer(s) either outgrow from the basal cells in clumps or remain attached in scattered groups from the time of seeding on top of the basal cells (20). Three days after plating, the superficial cells usually stain positive for trypan blue, and most are removed after gentle washing of the apical surface of the culture. The superficial cells do not affect the electrical or flux measurements (13, 19, 20). In the present study, we used cultures obtained by plating at a high density to control better the timing of treatments (see below); the results were similar in cultures plated at low vs. high density (not shown).CaSki cells were grown and maintained routinely in regular medium enriched with FCS as described previously (17, 20). In some experiments, cells were shifted to a medium enriched with FCS that was delipidized [retinoid-free medium (RFM)] to remove vitamin A. Serum delipidization was done as described previously (2, 14); briefly, FCS was added to a cooled (4°C) mixture of ethanol and acetone (1:5:5, vol/vol/vol) and mixed slowly for 4 h at 4°C. The solution was brought to room temperature and filtered twice. The protein residue was washed with ether and dried, resuspended in 2:1 vol/vol of water, frozen, and lyophilized twice for 48 h. The residue was resuspended in water to yield a protein concentration similar to the untreated serum, and aliquots of 10× PBS (pH 7.4) were added to adjust salts to isotonic conditions.
CaSki cells on filters change their permeability characteristics within the first week after plating (17). The present studies were timed for electrophysiological experiments to be conducted 4-5 days after plating (usually 4), so that it was possible to compare between different treatment groups. Because incubations in RFM required more than 6 days to exert significant effects (Ref. 14 and see RESULTS below), cells were shifted to RFM before they were plated on filters; this involved in some cases subculturing cells on regular culture dishes in RFM. For experiments, we also plated parallel filters with cells that were grown in regular culture medium to serve as controls. For each time point, we had at least three filters of test cells and three filters of parallel controls. Cells treated with retinoids were maintained in darkness until the Ussing chamber experiments.
Electrophysiological Experiments
Changes in paracellular resistance were determined in terms of changes in the transepithelial electrical resistance (RTE). For electrophysiological experiments, cells were plated on collagen-coated Anocell filters (ceramic base) as described (19), and levels of RTE were determined 4-5 days after plating on filters. Before experiments, filters containing cells were washed three times and preincubated for 10 min at 37°C in a modified Ringer buffer composed of (in mM) 120 NaCl, 5 KCl, 10 NaHCO3 (before saturating with 95% O2-5% CO2), 1.2 CaCl2, 1 MgSO4, 5 glucose, 10 HEPES, pH 7.4, and 0.1% BSA in volumes of 4.7-5.2 ml in the luminal and subluminal compartments. Drugs were added from 1,000× stocks to both the luminal and subluminal solutions; vehicles had no effect. Changes in RTE were calculated continuously across filters mounted in a modified Ussing chamber from successive measurements of the short-circuit current (Isc; normalized to the 0.6-cm2 surface area of the filter) and the transepithelial potential difference (PD; lumen negative), switching between Isc and PD at a rate of 20 Hz (19): RTE =Determinations of the Dilution Potential
Determinations of the dilution potential (Vdil) were described previously (19). Transepithelial Vdil were determined by measuring the effect of lowering NaCl in the luminal solution on changes in voltage generated across the epithelium. This was done by replacing the Ringer buffer in the luminal compartment (130 mM NaCl) with low (10 mM) NaCl solution. Vdil is the measured PD (subluminal voltageStatistical Analysis of the Data
Data are presented as means ± SD, and significance of differences among means was estimated by Student's t-test. Trends were calculated using GB-STAT V5.3 (Dynamic Microsystems, 1995, Silver Spring, MD) and analyzed with ANOVA. Best fit of regression equations (least squares criterion) was achieved with SlideWrite Plus 1993 (Advanced Graphics Software, Carlsbad, CA), which uses the Levenberg-Marquardt algorithm, and analyzed using ANOVA. Variance among experiments (interassay variability) ranged from 15 to 27%. Variance within experiments (intra-assay variability) ranged from 5 to 8%, and all trends were consistent among experiments. Comparisons among experiments were normalized to control measurements.Chemicals and Supplies
Anocell (Anocell-10) filters were obtained from Anotec (Oxon, UK). 9-cis-Retinoic acid, TTNPB, SRI-11217, and SRI-11237 were synthesized in the Department of Chemistry at Allergen (Irvine, CA). TTNPB is a potent synthetic RAR-selective retinoid, whereas SRI-11217 and SRI-11237 are RXR-selective synthetic retinoids (2). All other chemicals were obtained from Sigma Chemical (St. Louis, MO). Agonists were prepared as 1,000× stocks in saline or in DMSO and kept in dark conditions. ![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Effects of RFM on Phase I and Phase II Responses
In CaSki cells on filters, extracellular ATP (50 µM) stimulates a biphasic change in RTE. The changes in resistance are the composite of two distinct effects (17-19): an acute decrease in the RLIS (phase I response) from 10 to 8
|
|
To study how retinoids modulate the effects of extracellular ATP on changes in RTE, cells were grown in RFM. The timing of treatment with RFM depended on the desired length of exposure to retinoid-free conditions. For exposure of <4 days, cells plated on filters in regular culture medium were shifted to RFM for the required lengths of time. For longer exposures to retinoid-free conditions, cells grown on culture dishes were shifted to RFM and then were harvested and plated on filters in RFM for the total required length of time. For each time point, there were parallel control filters of cells that were grown in regular culture medium, and the results were normalized to these controls.
In the experiment shown in Fig. 1, cells were tested 1-11 days after treatment with RFM. For example, cells in the first time point (1 day after shifting to RFM) were plated on filters and maintained in regular culture medium for 3 days and then were shifted to RFM for 1 day before the Ussing chamber experiments. In contrast, cells at the 11-day treatment point were grown on culture dishes and shifted to RFM for 5 days; when subconfluence was reached, cells were subcultured on culture dishes in RFM for 2 additional days, harvested, and plated on filters in RFM for 4 days before the Ussing chamber experiments. Cells were therefore exposed to retinoid-free conditions for a total of 11 days. The controls were cells grown in regular culture medium in culture dishes that were then subcultured and plated on filters for the same time periods.
Incubation of cells for 11 days in RFM increased baseline RTE by 50% compared with parallel control cells that were grown in regular culture medium (Fig. 1A, Table 1) (14). To determine the effect of RFM on the ATP-induced changes in RTE, we compared the changes in phase I and phase II responses in cells grown in RFM to those obtained in cells grown in regular medium. Phase I response was determined as the acute decrease in resistance (baseline RTE minus trough of decrease in RTE); phase II response was determined as the late increase in resistance (the plateau of the increase in RTE minus baseline RTE) (Fig. 1A). Effects of retinoic acid on phase I and phase II responses were then normalized to the changes in RTE in cells grown in parallel filters in regular culture medium.
In cells grown in RFM for 11 days, both phase I and phase II responses were abolished (Fig. 1A). The loss of phase I and phase II responses was time related to the length of incubation in RFM. Phase I decreases in RTE were attenuated after 4 days of incubation in RFM and were abolished after 9-11 days. In contrast, phase II increases in RTE were attenuated already after 1 day of incubation in RFM and were abolished after 4-5 days (Fig. 1B, Table 1).
To determine whether the effects of RFM on phase I and on phase II responses are reversible, cells grown for 9 days in RFM were shifted back to regular medium for 2 days. A total of 11 days was chosen because it was the length of incubation in RFM necessary to abolish the responses to ATP (Fig. 1B). Both baseline resistance as well as the ATP-induced changes in RTE were similar to those for cells grown continuously in regular medium (Table 1).
Effects of Retinoids on Phase I and Phase II Responses.
To determine whether the effects of RFM on phase I and on phase II responses can be reversed with retinoids, cells grown in culture dishes were shifted to RFM for 5 days and then plated on filters in the same medium. After 3 days, cells were treated with 100 nM of retinoic acid for 6-48 h before the Ussing chamber experiments (total of 5 days on filters); controls were cells plated on filters in regular culture medium for 5 days. Retinoic acid had no acute effect on baseline RTE or on changes in resistance in response to ATP in cells grown in RFM (not shown), and longer incubations with the drug were needed to exert effects on resistance. Forty-eight hours after 100 nM retinoic acid was added, baseline resistance decreased from 16 to 9
|
In cells incubated with RFM, retinoic acid also modulated the phase II increase in resistance. In contrast to the effect of retinoic acid on phase I response, the effect of retinoic acid on phase II response began only 12 h after the drug was added, and the amplitude of phase II response was restored only to about one-half the amplitude in cells grown in regular medium (Fig. 2, Table 1).
The effects of retinoic acid on phase
I and on phase II
responses were dose dependent (Fig. 3).
These experiments were conducted as in Fig.
1B: cells grown in culture dishes were
shifted to RFM for 5 days and then plated on filters in the same
medium. After 2 days, cells were treated with one of the different
concentrations of retinoic acid (Fig. 3) for 2 additional days.
Phase I decreases in
RTE began with
1012 M and were maximal
with 10
9 M retinoic acid
(Fig. 3). The dose-response curve was sigmoidal, and the
data of Fig. 3 were fitted to a modified Hill equation with
half-maximal effective concentration
(K1/2) of
retinoic acid of 0.12 ± 0.03 nM and a Hill coefficient
(n) of 1.1 ± 0.3 (P < 0.01). Phase
II increases in
RTE began at
retinoic acid concentrations of
10
10 nM and reached
saturation at 10
8 nM (Fig.
3). The amplitude of the restored phase
II response was about one-half of the amplitude of
phase II response in cells grown in
regular medium (Fig. 3). The dose-response curve for phase II response was sigmoidal, and
the data of Fig. 3 were also fitted to a modified Hill equation with
K1/2 of retinoic acid of 1.0 ± 0.2 nM and n of 1.1 ± 0.2 (P < 0.01). These results indicate that retinoic acid has a more potent and efficacious effect on
the phase I than on the
phase II response and that
phase II response in cells incubated
in RFM can be restored only in part by retinoic acid.
|
In addition to retinoic acid, other retinoids also modulated the effects of ATP on RTE. These experiments were conducted in a similar manner, as was described above for Fig. 3. TTNPB (an RAR-selective ligand), SRI-11217 and SRI-11237 (RXR-selective ligands), and 9-cis-retinoic acid (a panagonist; i.e., binds both RAR and RXR subtypes) restored phase I response in a dose-related manner, similar to the effect of retinoic acid (Fig. 4A). For each of the retinoids, the K1/2 was ~0.2 nM and n was ~1.0. In contrast to the effect on the phase I response, only 9-cis-retinoic acid and TTNPB restored the late increase in RTE in response to ATP (Fig. 4A), with K1/2 of 2 nM (9-cis retinoic acid) and 3 nM (TTNPB) and n of 1.2 and 1.1, respectively.
|
To determine the efficacy of the RAR- vs. RXR-selective ligands in restoring changes in resistance in response to ATP, cells grown in RFM were treated with retinoids, added at a concentration of 100 nM, which produces maximal effects on phase I or phase II response (Figs. 3 and 4A). Each of the tested retinoids restored the phase I decrease in RTE to near the same degree as in cells grown in a regular medium (Fig. 4B). Only retinoic acid, 9-cis-retinoic acid, and TTNPB restored phase II increases in RTE, and the amplitude of the restored phase II response was about one-half of that in cells grown in regular medium (Fig. 4B).
Mechanisms of Retinoid Effects
Effects of actinomycin D on ATP-induced changes in RTE. Retinoids modulate cell functions via several known mechanisms, including transcription regulation (2). The objective of the next experiment was to study the effects of the transcription inhibitor actinomycin D on the ATP-induced phase I and phase II responses in cells treated with retinoic acid. Cells grown in culture dishes were shifted to RFM for 5 days, then plated on filters in the same medium for 2 days, and treated with 100 nM retinoic acid for 2 additional days. Actinomycin D (10 µM) was added for 0.5-2.5 h before the Ussing chamber experiments. The controls were cells grown in regular culture medium in culture dishes and filters for the same time periods that were treated with actinomycin D or with the vehicle 0.5-2.5 h before the Ussing chamber experiments.
For day 4 control cells on filters, actinomycin D had no effect on baseline resistance and on the phase I response to ATP. In contrast, incubation with actinomycin D for 2.5 h attenuated the phase II response by ~25% compared with cells not treated with actinomycin D: a net increase in RTE in response to ATP of 4.5 ± 0.5 vs. 6.2 ± 0.5
|
Effects of ionomycin, histamine, KCl, and 1,2-dioctanoyl-sn-diglycerol on changes in RTE. The objective of the next set of experiments was to determine how retinoids modulate the effects of agents that produce phase I-like and phase II-like responses by bypassing the P2U receptor(s). Phase I-like decreases in RTE were induced by ionomycin and by histamine; phase II-like increases in RTE were induced by KCl-dependent membrane depolarization (18) or by 1,2-dioctanoyl-sn-diglycerol (diC8) (17). Cells grown in culture dishes were shifted to RFM for 5 days, then plated on filters in the same medium for 2 days, and treated with 100 nM retinoic acid or the vehicle for 2 additional days. The controls were cells grown in regular culture medium in culture dish and filters for the same time periods.
Ionomycin decreased RTE by ~5
|
|
Modulation of RLIS and RTJ. To determine whether in retinoid-treated cells ATP activates changes in RLIS or in RTJ, we measured the effects of ATP on changes in the Vdil and we calculated the effects on the ratio of mobilities of chloride and sodium (uCl/uNa). The rationale was that cation selectivity is a property of the tight junctions, and changes in uCl/uNa reflect modulation of RTJ (24). Cells grown in culture dishes were shifted to RFM for 5 days, then plated on filters in the same medium for 2 days, and treated with 100 nM retinoic acid or the vehicle for 2 additional days. The controls were cells grown in regular culture medium in culture dishes and filters for the same time periods. Before ATP was added, NaCl in the luminal side was lowered from 130 to 10 mM to establish a Vdil, and changes in uCl/uNa were determined as described in METHODS. The level of uCl/uNa across cells incubated in RFM plus retinoic acid was 1.34 ± 0.09, similar to those across control cells (1.33 ± 0.08, P > 0.4, Fig. 8). In cells exposed to low NaCl in the luminal solution, ATP produced biphasic changes in RTE similar to those obtained under symmetrical NaCl concentrations of 130 mM (compare Figs. 8 and 1A). The uCl/uNa decreased in a time-related manner after ATP was added, and the decrease in uCl/uNa correlated in time with the phase II response but not with the phase I response (Fig. 8), indicating that phase II increases in RTE in retinoid-treated cells are associated with increased cation selectivity.
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The present results indicate that retinoids modulate the effects of extracellular ATP on paracellular resistance in human cervical cells. The experiments were done with human CaSki cells, which are a good model for the endocervical epithelium, based on morphological, biochemical, and molecular criteria (20). Also, the permeability characteristics of the cultured cervical cells are similar to those of the endocervical epithelium (14).
The present results indicate that RFM (i.e., vitamin A deficiency) abrogates and retinoids restore the ATP-induced phase I decrease in RLIS and the phase II increase in RTJ. Neither vitamin A deficiency nor retinoids had toxic effects on the cells because 1) phase I- and phase II-like changes in RTE could be evoked in vitamin A-deficient cells with agents that act distal to the P2U receptor(s), regardless of treatment with retinoids, and 2) shifting cells grown in RFM to a medium enriched with retinoid-containing serum restored baseline resistance and the changes in RTE in response to ATP. The data further support the theory that phase I and phase II changes in RTE are mediated by two distinct signal mechanisms (17, 18) because phase I and phase II responses differed with regard to 1) the time course of the effects of vitamin A deficiency and retinoid treatment on changes in RTE, 2) the retinoid agonists profile, 3) the dose requirements for retinoids necessary to restore phase I and phase II responses, and 4) the responses to actinomycin D.
Incubation of cervical cells in medium with delipidized serum resulted in an increased baseline RTE, and it abrogated phase I response; however, it had no effect on phase I-like decreases in resistance induced by ionomycin and histamine. It was previously suggested that decreases in RTE induced by ATP, ionomycin, and histamine are mediated by a common signaling mechanism (17, 18), and the present results suggest that retinoids modulate a proximal step in the ATP-dependent stimulus, such as the P2U-purinergic receptor.
Incubation of cervical cells in medium with delipidized serum also abrogated phase II response and attenuated the increases in RTJ in response to KCl or diC8. Neither of these effects could be reversed completely by retinoic acid. This is in contrast to the effect of retinoic acid on baseline resistance (14). It was previously shown (14), and confirmed in the present study, that delipidized serum increases baseline paracellular resistance mainly by increasing RTJ. In addition, retinoic acid reversed the effect of delipidized serum and decreased RTJ (14). These results suggest that delipidized serum and retinoids have a number of different effects on the tight junctions in human cervical cells and they may modulate RTJ by different mechanisms, e.g., regulation of the junctional complexes (which determine the baseline resistance), vs. regulation of the P2U receptor signaling cascade that activates an increase in RTJ (phase II response).
The molecular mechanisms of retinoid action on cervical cells are only partially understood. Retinoids act via nuclear receptors that are known to be expressed in human cervical cells (1-3, 8, 11, 21). The present results suggest that the phase II increase in resistance is mediated via nuclear retinoid receptors. 1) Retinoic acid restored the phase II response within 6-12 h of treatment, a length of time compatible with transcription regulation. 2) The low concentration of retinoic acid (K1/2 of 1 µM) correlates with the dissociation constant of the retinoid receptors (9, 10). 3) The dose-response curve of increase in resistance in response to ATP vs. retinoic acid concentrations was saturable and was fitted by a modified Hill equation with n = 1. 4) Phase II response was restored in cells treated with RAR-selective or RAR/RXR-selective ligands but not by RXR-selective ligands. 5) Actinomycin D inhibited the retinoic acid-induced effect on phase II response but not the KCl- or diC8-induced increases in resistance. It was suggested that KCl induces an increase in RTJ by stimulating calcium influx, an early step in the phase II response (18). A possible interpretation of the present data is therefore that retinoids, acting via an RAR, upregulate transcription or inhibit degradation of a message in the signaling cascade proximal to calcium influx.
In contrast to the effect on phase II response, longer incubation in RFM was required to eliminate phase I response (4 vs. 11 days, respectively), and phase I response was restored earlier after retinoic acid was added (<6 h). Also, retinoic acid had a more potent effect on the phase I response (K1/2 of 0.1 µM). Moreover, the phase I response was restored both with RAR- and with RXR-selective retinoids, and actinomycin D had little effect on the phase I response. Interestingly, vitamin A deprivation eliminated phase I response but not the ionomycin-induced decrease in resistance. This suggests that vitamin A deficiency downregulates and that retinoids upregulate necessary step(s) in the signaling cascade proximal to calcium mobilization.
Vitamin A and related ligands produce multiple effects on cervical epithelial cells (1-3, 8, 11, 21). The present study adds to this list and suggests that retinoids determine the degree of RTJ of endocervical cells and regulate the responses to extracellular ATP. Because plasma levels of vitamin A are tightly regulated (9, 10), the net effect on transcervical permeability may depend on changes in the expression of nuclear RAR or RXR, changes in retinoid metabolism, and/or the concentration of ATP in the extracellular fluid. Previous studies in rodents suggest that levels of retinoid receptors in the cervix change during the estrous cycle (5, 28, 29). The present results therefore raise the possibility that sex steroid hormones regulate cervical mucus secretion indirectly by modulating tissue levels of retinoid receptors and that the retinoid receptors, in turn, control the degree of occlusion of the intercellular space by the tight junctions and the responses to extracellular ATP.
Vitamin A-dependent regulation of baseline paracellular resistance and the responses to ATP may be important in vivo for regulation of cervical mucus because even small changes in RTE may have profound effects on fluid and solute secretion. Release of ATP into the extracellular space from nerve endings or from cells that participate in the inflammatory process can stimulate the phase I response and decrease RLIS and therefore can enhance secretion of fluids and solutes from the blood into the cervical canal. Vitamin A would tend to increase transcervical permeability because retinoids decrease baseline RTJ, and phase I decreases in RLIS are more sensitive to the effects of retinoids than the phase II increases in RTJ (present results). These data correlate with the observations in vivo that vitamin A deficiency leads to dryness of the endocervix (i.e., diminished transudation of fluids from the blood into the lumen across the cervical epithelium), whereas treatment with vitamin A reverses the condition (9, 10).
The role in vivo of phase II increases in RTJ, on the other hand, is less well understood. An ATP-induced increase in RTJ would tend to decrease transcervical transport and diminish production of cervical mucus. It is possible that, under certain pathological conditions in vivo, e.g., inflammation of the cervix, that are associated with excessive secretion of cervical mucus (12), the phase II response will tend to diminish the secretion of fluids from blood into the lumen.
![]() |
ACKNOWLEDGEMENTS |
---|
This study was supported by National Institute of Child Health and Human Development Grants HD-00977 and HD-29924 (to G. I. Gorodeski) and a grant from the American Institute for Cancer Research (to R. L. Eckert). These studies used the facilities of the Skin Diseases Research Center of Northeast Ohio (National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR-39750).
![]() |
FOOTNOTES |
---|
Present address of P. Burfeind: Institute of Human Genetics, Georg-August-University, Gosslerstr. 12D, D-37073 Goettingen, Germany
Address for reprint requests: G. I. Gorodeski, Univ. MacDonald Womens Hospital, Univ. Hospitals of Cleveland, 11100 Euclid Ave., Cleveland, OH 44106.
Received 4 November 1997; accepted in final form 9 January 1998.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Agarwal, C.,
R. A. S. Chandraratna,
A. T. Johnson,
E. A. Rorke,
and
R. L. Eckert.
AGN193109 is a highly effective antagonist of retinoid action in human ectocervical epithelial cells.
J. Biol. Chem.
271:
12209-12212,
1996
2.
Agarwal, C.,
R. A. S. Chandraratna,
M. Teng,
S. Nagpal,
E. A. Rorke,
and
R. L. Eckert.
Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid x receptor- and retinoic acid receptor-specific retinoids.
Cell Growth Differ.
7:
521-530,
1996[Abstract].
3.
Agarwal, C.,
E. A. Rorke,
J. C. Irwin,
and
R. L. Eckert.
Immortalization by human papillomavirus type 16 alters retinoid regulation of human ectocervical epithelial cell differentiation.
Cancer Res.
51:
3982-3989,
1991[Abstract].
4.
Born, G. V. R.,
and
M. A. A. Kratzer.
Source and concentration of extracellular adenosine triphosphate during hemostasis in rats, rabbits and man.
J. Physiol. (Lond.)
354:
419-429,
1992[Abstract].
5.
Bucco, R. A.,
M. H. Melner,
D. S. Gordon,
S. D. Leers-Sucheta,
and
D. E. Ong.
Inducible expression of cellular retinoic acid-binding protein II in rat ovary: gonadotropin regulation during luteal development.
Endocrinology
136:
2730-2740,
1995[Abstract].
6.
Burnstock, G.
Purinoceptors: ontogeny and phylogeny.
Drug Dev. Res.
39:
204-242,
1996.
7.
Dalziel, H. H.,
and
D. P. Westfall.
Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization.
Pharmacol. Rev.
46:
449-466,
1994[Medline].
8.
Darwiche, N.,
G. Celli,
and
L. M. De Luca.
Specificity of retinoid receptor gene expression in mouse cervical epithelia.
Endocrinology
134:
2018-2025,
1994[Abstract].
9.
Deluca, L. M.
Vitamin A.
In: Handbook of Lipid Research, edited by H. F. Deluca. New York: Plenum, 1978, vol. 2, p. 1-67.
10.
Elias, P. M.,
and
M. L. Williams.
Retinoids, cancer and the skin.
Arch. Dermatol.
117:
160-180,
1981[Abstract].
11.
Giguere, V.
Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling.
Endocr. Rev.
15:
61-79,
1994[Medline].
12.
Gorodeski, G. I.
The cervical cycle.
In: Reproductive Endocrinology, Surgery, and Technology, edited by E. Y. Adashi,
J. A. Rock,
and Z. Rosenwaks. Philadelphia, PA: Lippincott-Raven, 1996, p. 301-324.
13.
Gorodeski, G. I.,
B. J. De Santis,
J. Goldfarb,
W. H. Utian,
and
U. Hopfer.
Osmolar changes regulate the paracellular permeability of cultured human cervical epithelium.
Am. J. Physiol.
269 (Cell Physiol. 38):
C870-C877,
1995
14.
Gorodeski, G. I.,
R. L. Eckert,
D. Pal,
W. H. Utian,
and
E. A. Rorke.
Retinoids regulate tight junctional resistance of cultured human cervical cells.
Am J. Physiol.
273 (Cell Physiol. 42):
C1707-C1713,
1997
15.
Gorodeski, G. I.,
R. L. Eckert,
W. H. Utian,
L. Sheean,
and
E. A. Rorke.
Retinoids, sex steroids and glucocorticoids regulate ectocervical cell envelope formation but not the level of the envelope precursor, involucrin.
Differentiation
42:
75-80,
1989[Medline].
16.
Gorodeski, G. I.,
R. L. Eckert,
W. H. Utian,
L. Sheean,
and
E. A. Rorke.
Cultured human ectocervical epithelial cell differentiation is regulated by the combined direct actions of sex steroids, glucocorticoids and retinoids.
J. Clin. Endocrinol. Metab.
70:
1624-1630,
1990[Abstract].
17.
Gorodeski, G. I.,
U. Hopfer,
B. J. De Santis,
R. L. Eckert,
E. R. Rorke,
and
W. H. Utian.
Biphasic regulation of paracellular permeability in human cervical cells by two distinct nucleotide receptors.
Am. J. Physiol.
268 (Cell Physiol. 37):
C1215-C1226,
1995
18.
Gorodeski, G. I., U. Hopfer, and J. Wenwu.
Purinergic receptor induced changes in paracellular resistance
across cultures of human cervical cells are mediated by two distinct
cytosolic calcium related mechanisms. Cell Biochem.
Biophys. In press.
19.
Gorodeski, G. I.,
D. Peterson,
B. J. De Santis,
and
U. Hopfer.
Nucleotide receptor-mediated decrease of tight-junctional permeability in cultured human cervical epithelium.
Am. J. Physiol.
270 (Cell Physiol. 39):
C1715-C1725,
1996
20.
Gorodeski, G. I.,
M. F. Romero,
U. Hopfer,
E. Rorke,
W. H. Utian,
and
R. L. Eckert.
Human uterine cervical epithelial cells grown on permeable supporta new model for the study of differentiation and transepithelial transport.
Differentiation
56:
107-118,
1994[Medline].
21.
Hembree, J. R.,
C. Agarwal,
R. L. Beard,
R. A. S. Chandraratna,
and
R. L. Eckert.
Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
Cancer Res.
56:
1794-1799,
1996[Abstract].
22.
Kennedy, C.,
and
A. Izerman.
Adenosine and ATP: from receptor structure to clinical applications.
Trends Pharmacol. Sci.
15:
311-312,
1994[Medline].
23.
Merlin, D.,
C. Augeron,
X.-Y. Tien,
X. Guo,
C. L. Laboisse,
and
U. Hopfer.
ATP-stimulated electrolyte and mucin secretion in the human intestinal goblet cell line HT29-CL.16E.
J. Membr. Biol.
137:
137-149,
1994[Medline].
24.
Reuss, L.
Tight junction permeability to ions and water.
In: Tight-Junctions, edited by M. Cereijido. Boca Raton, FL: CRC, 1991, p. 49-66.
25.
Rothblat, G. H.,
L. Y. Arborgast,
L. Quellett,
and
B. V. Howard.
Preparation of delipidized serum protein for use in cell culture systems.
In Vitro
12:
554-557,
1976[Medline].
26.
Schultz, S. G.
Diffusion potentials.
In: Basic Principles of Membrane Transport. Cambridge, UK: Cambridge University Press, 1980, p. 42-56.
27.
Silensky, E. M.
On the association between transmitter secretion and the release of adenine nucleotides from mammalian motor nerve terminals.
J. Physiol. (Lond.)
247:
145-162,
1975[Abstract].
28.
Tannous-Khuri, L.,
P. Hillemanns,
N. Rajan,
T. C. Wright,
and
D. A. Talmage.
Expression of cellular retinol- and cellular retinoic acid-binding proteins in the rat cervical epithelium is regulated by endocrine stimuli during normal squamous metaplasia.
Am. J. Pathol.
144:
148-159,
1994[Abstract].
29.
Van der Leede, B. J.,
G. E. Folkers,
C. E. Van den Brink,
P. T. Van der Saag,
and
B. Van der Burg.
Retinoic acid receptor alpha 1 isoform is induced by estradiol and confers retinoic acid sensitivity in human breast cancer cells.
Mol. Cell. Endocrinol.
109:
77-86,
1995[Medline].